Agrow is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


PHC revenues down 13% in first half

The US-based, UK-listed bioproducts company, Plant Health Care (PHC - Raleigh, North Carolina), recorded a 12.9% drop in revenues to $3.3 million in the first half of 2014. The company attributes the decline to milestone payments of licence revenue for the disease resistance activator, Harpin αβ, in the first half of 2013. Sales of the core products, Harpin αβ, and the drought resistance product, Myconate, more than doubled to $1.8 million. Revenues associated with Harpin αβ and Myconate accounted for 53% of the total in the first half of 2014 compared with 43% in the same period last year.



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts